Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2603PDF: 853HTML: 1752 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3199PDF: 943HTML: 6620Untitled: 282Untitled: 241Untitled: 259Untitled: 265 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
126PDF: 93Suppl. Files: 18Html: 21Html Suppl. Files: 19 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3455PDF: 1032HTML: 3015 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9420PDF: 6265HTML: 88200Fig.1b: 265Fig.1c: 261Fig.2a: 257Fig.2b: 252Fig.4: 269Fig.2c: 243Fig.3: 247Tab.1: 313Tab.2: 286Tab.3: 273Tab.4: 305Fig1a: 258 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2811PDF: 827HTML: 2333 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3050PDF: 1085HTML: 5664 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2650PDF: 1793HTML: 698 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1999PDF: 1086HTML: 254 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1672HTML: 696PDF: 914 -
-
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2686PDF: 1668HTML: 720 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3051PDF: 1172HTML: 135 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
4100PDF: 819HTML: 1898 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2060PDF: 872HTML: 2224Table 1: 230Table 2: 245Table 3: 241Table 4: 239Table 5: 236Tble 6: 233Cover Letter: 247Greene Tab.7: 252 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3849PDF: 969HTML: 6887 -
-
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2349PDF: 781HTML: 361
1 - 31 of 31 items







